Parkinson disease (PD) is a progressive neurodegenerative disease that leads to a wide range of motor and non-motor deficits. Specifically, voice and swallow deficits manifest early, are devastating to quality of life, and are difficult to treat with standard medical therapies. The pathological hallmarks of PD include accumulation of the presynaptic protein alpha-synuclein as well as degeneration of substantia nigra dopaminergic neurons. However, there is no clear understanding of how or when this pathology contributes to voice and swallow dysfunction in PD. In the present study, we evaluated the effect of loss of function of the PTEN-induced putative kinase 1 gene in rats (PINK1 −/−), a model of autosomal recessive PD in humans, on vocalization, oromotor and limb function, and neurodegenerative pathologies. Behavioral measures included ultrasonic vocalizations, tongue force, biting, and gross motor performance that were assayed at 2, 4, 6, and 8 months of age. Aggregated alpha-synuclein and tyrosine hydroxylase immunoreactivity were measured at 8 months. We show that compared to wildtype controls PINK1 −/− rats develop (1) early and progressive vocalization and oromotor deficits; (2) reduced tyrosine hydroxylase immunoreactivity in the locus coeruleus that correlates with vocal loudness and tongue force; and (3) alpha-synuclein neuropathology in brain regions important for cranial sensorimotor control. This novel approach of characterizing a PINK1 −/− genetic model of PD provides the foundational work necessary to define behavioral biomarkers for the development of disease-modifying therapeutics for PD patients.

Parkinson disease (PD) is a complex, progressive, neurodegenerative disorder that leads to a wide range of deficits including fine and gross sensorimotor impairment, autonomic dysfunction, mood disorders, and cognitive decline. Traditionally, the focus for diagnosis and treatment has been on sensorimotor impairment related to dopamine depletion. It is now widely recognized, however, that PD-related pathology affects multiple central nervous system neurotransmitters and pathways. Communication and swallowing functions can be impaired even in the early stages, significantly affecting health and quality of life. The purpose of this article is to review the literature on early intervention for communication and swallowing impairment in PD. Overarching themes were that (1) studies and interpretation of data from studies in early PD are limited; (2) best therapy practices have not been established, in part due to the heterogeneous nature of PD; and (3) as communication and swallowing problems are pervasive in PD, further treatment research is essential.